Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.UK based Fulcrum Pharma has appointed Frank Armstrong as its new CEO as of April 1, 2008.
Subscribe to our email newsletter
Most recently, Dr Armstrong was president and CEO of CuraGen, from March 2006 until September 2007. Prior to CuraGen, Mr Armstrong was CEO of Bioaccelerate Holdings, Provensis and Phoqus Pharmaceuticals.
Dr Armstrong has more than 20 years of experience at major pharmaceutical and leading biotechnology companies where he has been integral in bringing new pharmaceutical products to the market.
Mr Jon Court, the current CEO, will work closely with Mr Frank Armstrong and the senior management team at Fulcrum in his new role as director of strategic business development.